Advertisement
Advertisement
CERS
Cerus Corp
1.95
USDSponsored
-0.12
-5.80%
Nov 10, 15:59 UTC -5
Closed
After-Market
1.99
+0.04
+2.05%
Cerus Corp (CERS) Earnings
CERS Earnings Reports
Positive Surprise Ratio
CERS beat 27 of 44 last estimates.
61%
Next Report
Date of Next Report
Mar 01, 2027
Estimate for Q4 26 (Revenue/ EPS)
$67.55M
/$0.00
Implied change from Q3 26 (Revenue/ EPS)
+17.04%
/--
Implied change from Q4 25 (Revenue/ EPS)
+25.88%
/-100.00%
Cerus Corp earnings per share and revenue
On Nov 02, 2026, CERS reported earnings of 0.00 USD per share (EPS) for Q3 26, beating the estimate of -0.01 USD, resulting in a 100.00% surprise. Revenue reached 57.71 million, compared to an expected 62.93 million, with a -8.29% difference. The market reacted with a -0.85% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 0.00 USD, with revenue projected to reach 67.55 million USD, implying an increase of 0.00% EPS, and increase of 17.04% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Lumexa Imaging Holdings, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
$0.18
Actual
$0.26
Surprise
+39.63%
Capricor Therapeutics Inc
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.44
Actual
-$0.73
Surprise
-65.16%
Village Farms International, Inc. Common Shares
Report Date
Nov 09, 2026 For Q3 26
Estimate
$0.05
Actual
$0.08
Surprise
+48.42%
Canopy Growth Corporation Common Shares
Report Date
Nov 06, 2026 For Q2 27
Estimate
-$0.03
Actual
-$0.01
Surprise
+71.75%
OraSure Technologies Inc
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$0.20
Actual
-$0.15
Surprise
+28.26%
TriSalus Life Sciences, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.13
Actual
-$0.15
Surprise
-14.85%
Exagen Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.18
Actual
-$0.25
Surprise
-35.35%
Quanterix Corporation Common Stock
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$0.44
Actual
-$0.46
Surprise
-3.67%
Prestige Consumer Healthcare Inc.
Report Date
Nov 05, 2026 For Q2 27
Estimate
$1.08
Actual
$1.12
Surprise
+4.28%
Myomo Inc.
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$0.07
Actual
-$0.07
Surprise
+11.17%
FAQ
What were Cerus Corp's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Cerus Corp reported EPS of $0.00, beating estimates by 100%, and revenue of $57.71M, -8.29% below expectations.
How did the market react to Cerus Corp's Q3 2026 earnings?
The stock price moved down -0.85%, changed from $2.36 before the earnings release to $2.34 the day after.
When is Cerus Corp expected to report next?
The next earning report is scheduled for Mar 01, 2027.
What are the forecasts for Cerus Corp's next earnings report?
Based on --
analysts, Cerus Corp is expected to report EPS of -- and revenue of $67.55M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.